Advertisement
Advertisement

MESO

MESO logo

Mesoblast Limited - ADR

15.73
USD
Sponsored
+0.35
+2.28%
Jun 24, 10:26 UTC -4
Open

MESO Earnings Reports

Positive Surprise Ratio

MESO beat 9 of 12 last estimates.

75%

Next Report

Date of Next Report
Aug 26, 2026
Estimate for Q4 26 (Revenue/ EPS)
$66.66M
/
-$0.10
Implied change from Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q4 25 (Revenue/ EPS)
--
/
--

Mesoblast Limited - ADR earnings per share and revenue

On --, MESO reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 26, 4 analysts forecast an EPS of -0.10 USD, with revenue projected to reach 66.66 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
logo
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q-- --, Mesoblast Limited - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Aug 26, 2026.
Based on 4 analysts, Mesoblast Limited - ADR is expected to report EPS of -$0.10 and revenue of $66.66M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement